Long-Term Enterocystoplasty Follow-Up: Metabolic and Neoplastic Concerns

Current Bladder Dysfunction Reports

Volumn 9, Issue 4, 2014, Pages 302-309

  Avallone, Michael A ^a   Prince, Morgan K ^a   Guralnick, Michael L ^a   O’Connor, R Corey ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bladder augmentation; Complications; Enterocystoplasty

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CYANOCOBALAMIN; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

AUGMENTATION ENTEROCYSTOPLASTY; BACTERIURIA; BLADDER PERFORATION; BLADDER RECONSTRUCTION; BLADDER STONE; BODY GROWTH; BONE DISEASE; BONE MINERALIZATION; COLOCYSTOPLASTY; COLON; CYANOCOBALAMIN DEFICIENCY; ELECTROLYTE DISTURBANCE; GASTROCYSTOPLASTY; HUMAN; ILEOCYSTOPLASTY; ILEUM; JEJUNUM; METABOLIC ACIDOSIS; METABOLIC DISORDER; MUCUS SECRETION; NEOPLASM; OSTEOLYSIS; REVIEW; SPINAL DYSRAPHISM; STOMACH; TREATMENT OUTCOME;

EID: 84911970228     PISSN: 19317212     EISSN: 19317220     Source Type: Journal    
DOI: 10.1007/s11884-014-0266-3     Document Type: Review

References (66)

1. Von Mikulicz J. Zur operation der angebarenen blaßen-Spalte20. Zentralbl Chir. 1889;20:641–3.
2. Couvelaire R. La petite vessie des tuberculeux genito-urinaires: Essai de classification, places et variantes des cysto-intestinoplasties. J Urol (Paris). 1950;56:381–434.
3. Schlomer BJ, Saperston K, Baskin L. National trends in augmentation cystoplasty in the 2000s and factors associated with patient outcomes. J Urol. 2013;190(4):1352–7. Review of the Kids Inpatient database reported a 25 % decrease in the number of augmentation cystoplasties performed in the USA from 2000 to 2009. Hospital stay following surgery decreased by an average of 1 day, but 30% of patients had a complication during the initial post-operative hospitalization. Older age at time of surgery and exstrophy diagnosis were associated with longer hospital stay and increased odds of having a complication.
4. Peterson AC, Curtis LH, Shea AM, Borawski KM, Schulman KA, Scales Jr CD. Urinary diversion in patients with spinal cord injury in the United States. Urol. 2012;80(6):1247–51. In a review of the National Inpatient Sample, bladder augmentation was used in one third of cases to manage neurogenic bladder. The patients who undergo AE utilize fewer health care resources, and there was a lower augmentation rate at nonteaching institutions.
5. Zachoval R, Pitha J, Medova E, Heracek J, Lukes M, Zalesky M, et al. Augmentation cystoplasty in patients with multiple sclerosis. Urol Int. 2003;70(1):21–6. discussion 26.
6. Seisen T, Roupret M, Phe V, Bosset PO, Parra J, Drouin SJ, et al. Last resort surgical management of postradiation urinary cystitis after external beam radiation for prostate cancer: a monocentric analysis. Cancer Radiother. 2013;17(4):282–7.
7. Chung SD, Wang CC, Kuo HC. Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain. Neurourol Urodyn. 2013 Aug 29
8. Reyblat P, Ginsberg DA. Augmentation enterocystoplasty in overactive bladder: is there still a role? Curr Urol Rep. 2010;11(6):432–9.
9. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int. 2012;109(9):1280–93.
10. Gundeti MS, Acharya SS, Zagaja GP, Shalhav AL. Paediatric robotic-assisted laparoscopic augmentation ileocystoplasty and Mitrofanoff appendicovesicostomy (RALIMA): feasibility of and initial experience with the university of Chicago technique. BJU Int. 2011;107(6):962–9.
11. Rey D, Helou E, Oderda M, Robbiani J, Lopez L, Piechaud PT. Laparoscopic and robot-assisted continent urinary diversions (Mitrofanoff and Yang-Monti conduits) in a consecutive series of 15 adult patients: the Saint Augustin technique. BJU Int. 2013;112(7):953–8.
12. Tanrikut C, McDougal WS. Acid–base and electrolyte disorders after urinary diversion. World J Urol. 2004;22(3):168–71.
13. Gosalbez Jr R, Woodard JR, Broecker BH, Warshaw B. Metabolic complications of the use of stomach for urinary reconstruction. J Urol. 1993;150(2 Pt 2):710–2.
14. Hensle TW, Gilbert SM. A review of metabolic consequences and long-term complications of enterocystoplasty in children. Curr Urol Rep. 2007;8(2):157–62.
15. Stein R, Schroder A, Thuroff JW. Bladder augmentation and urinary diversion in patients with neurogenic bladder: non-surgical considerations. J Pediatr Urol. 2012;8(2):145–52.
16. Mitsui T, Moriya K, Kitta T, Kon M, Nonomura K. Preoperative renal scar as a risk factor of postoperative metabolic acidosis following ileocystoplasty in patients with neurogenic bladder. Spinal Cord. 2014;52(4):292–4. In a series of pediatric spina bifida patients with normal pre-op renal function based on serum chemistry, a 43% rate of metabolic acidosis was observed. A significantly higher rate of metabolic acidosis was found in patients with renal scar on DMSA scintigraphy 79 % vs. those without scar 13 %.
17. Rubenwolf PC, Beissert A, Gerharz EW, Riedmiller H. 15 years of continent urinary diversion and enterocystoplasty in children and adolescents: the Wurzburg experience. BJU Int. 2010;105(5):698–705. Over a median follow-up of 7.3 years, the authors review outcomes in children who underwent continent urinary diversion or AE. Intervention for urolithiasis was required in 19%, and 41% were started on alkaline substitution for metabolic acidosis.
18. 12deficiency, acidosis, or bladder neoplasms
19. Koch MO, McDougal WS, Hall MC, Hill DE, Braren HV, Donofrio MN. Long-term metabolic effects of urinary diversion: a comparison of myelomeningocele patients managed by clean intermittent catheterization and urinary diversion. J Urol. 1992;147(5):1343–7.
20. Gros DA, Dodson JL, Lopatin UA, Gearhart JP, Silver RI, Docimo SG. Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy. J Urol. 2000;164(3 Pt 2):917–20.
21. Feng AH, Kaar S, Elder JS. Influence of enterocystoplasty on linear growth in children with exstrophy. J Urol. 2002;167(6):2552,5. discussion 2555.
22. Mingin GC, Nguyen HT, Mathias RS, Shepherd JA, Glidden D, Baskin LS. Growth and metabolic consequences of bladder augmentation in children with myelomeningocele and bladder exstrophy. Pediatrics. 2002;110(6):1193–8.
23. Taskinen S, Makitie O, Fagerholm R. Intestinal bladder augmentation at school age has no adverse effects on growth. J Pediatr Urol. 2008;4(1):40–2.
24. Gerharz EW, Preece M, Duffy PG, Ransley PG, Leaver R, Woodhouse CR. Enterocystoplasty in childhood: a second look at the effect on growth. BJU Int. 2003;91(1):79–83.
25. Ragavan M, Tandon N, Bhatnagar V. Exstrophy bladder: effect of sigmoid colocystoplasty on physical growth and bone mineral density. J Indian Assoc Pediatr Surg. 2011;16(2):45–9. In pediatric exstrophy patients treated with colocystoplasty, no significant effects on physical growth or bone mineralization were observed at a mean follow-up of 15 months.
26. Ponte SF, Rondon A, Bacelar H, Damazio E, Ribeiro SM, Garrone G, et al. Anthropometric measurements as an indicator of nutritional status in spina bifida patients undergoing enterocystoplasty. Einstein (Sao Paulo). 2013;11(2):168–73.
27. GREEN Jr RC, BOYD JA. Rickets secondary to chronic hyperchloremic acidosis in ureterosigmoidostomy. AMA Arch Intern Med. 1959;103(5):807–13.
28. Arnett TR. Acidosis, hypoxia and bone. Arch Biochem Biophys. 2010;503(1):103–9.
29. Mills RD, Studer UE. Metabolic consequences of continent urinary diversion. J Urol. 1999;161(4):1057–66.
30. Boylu U, Horasanli K, Tanriverdi O, Kendirci M, Gumus E, Miroglu C. Evaluation of bone mineral density after ileocystoplasty in children with and without myelomeningocele. Pediatr Surg Int. 2006;22(4):375–9.
31. Taskinen S, Fagerholm R, Makitie O. Skeletal health after intestinal bladder augmentation: findings in 54 patients. BJU Int. 2007;100(4):906–10.
32. Haas RE, Kecskemethy HH, Lopiccolo MA, Hossain J, Dy RT, Bachrach SJ. Lower extremity bone mineral density in children with congenital spinal dysfunction. Dev Med Child Neurol. 2012;54(12):1133–7. Bone mineral density (BMD) in children with spina bifida was found to be correlated with ambulation status and neurological level. History of bladder augmentation did not show a significant relationship to BMD.
33. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–60.
34. Oberley MJ, Yang DT. Laboratory testing for cobalamin deficiency in megaloblastic anemia. Am J Hematol. 2013;88(6):522–6.
35. Behrend C, Jeppesen PB, Mortensen PB. Vitamin B12 absorption after ileorectal anastomosis for Crohn’s disease: effect of ileal resection and time span after surgery. Eur J Gastroenterol Hepatol. 1995;7(5):397–400.
36. Canning DA, Perman JA, Jeffs RD, Gearhart JP. Nutritional consequences of bowel segments in the lower urinary tract. J Urol. 1989;142(2 Pt 2):509,11. discussion 520–1.
37. Rosenbaum DH, Cain MP, Kaefer M, Meldrum KK, King SJ, Misseri R, et al. Ileal enterocystoplasty and B12 deficiency in pediatric patients. J Urol. 2008;179(4):1544,7. discussion 1547–8.
38. 12level and length of follow-up
39. Blyth B, Ewalt DH, Duckett JW, Snyder HM. Lithogenic properties of enterocystoplasty. J Urol. 1992;148(2 Pt 2):575–7. discussion 578–9.
40. Szymanski KM, Misseri R, Whittam B, Amstutz S, Kaefer M, Rink RC, et al. Cutting for stone in augmented bladders—what is the risk of recurrence and is it impacted by treatment modality? J Urol. 2014;191(5):1375–80. Bladder stones were found to recur in 48 % of patients following treatment of stones in augmented bladders. There was no difference in rate of recurrence in patients treated with endoscopic versus open approaches.
41. Welk B, Herschorn S, Law C, Nam R. Population based assessment of enterocystoplasty complications in adults. J Urol. 2012;188(2):464–9. In a population based study, 243 patients were followed to determine the predictors of need for urologic surgery following AE. A simultaneous incontinence procedure predicted need for future surgery and catheterizable channels were associated with an increased risk for future cystolitholapaxy.
42. DeFoor W, Minevich E, Reddy P, Sekhon D, Polsky E, Wacksman J, et al. Bladder calculi after augmentation cystoplasty: risk factors and prevention strategies. J Urol. 2004;172(5 Pt 1):1964–6.
43. Kispal Z, Balogh D, Erdei O, Kehl D, Juhasz Z, Vastyan AM, et al. Complications after bladder augmentation or substitution in children: a prospective study of 86 patients. BJU Int. 2011;108(2):282–9. In reviewing 80 patients following AE with stomach, ileum and colon, a significantly higher rate of complications was reported in patients following colocystoplasty with a higher rate of stone formation and requirement for more post-operative interventions.
44. Veenboer PW, Ruud Bosch JL, van Asbeck FW, de Kort LM. Urolithiasis in adult spina bifida patients: study in 260 patients and discussion of the literature. Int Urol Nephrol. 2013;45(3):695–702. The authors report a 10 times increased rate of bladder stone formation in spina bifida patients compared to the general population. Independent risk factors for stone formation in spina bifida patients include recurrent UTI, incorporation of bowel into the urinary tract, and use of an indwelling catheter.
45. Rhee AC, Cain MP. Percutaneous cystolithotomy in the pediatric neuropathic bladder with laparoscopic trocar access: a modified approach useful for the augmented and native bladder, and continent urinary reservoir. J Pediatr Urol. 2013;9(3):289–92.
46. Hensle TW, Bingham J, Lam J, Shabsigh A. Preventing reservoir calculi after augmentation cystoplasty and continent urinary diversion: the influence of an irrigation protocol. BJU Int. 2004;93(4):585–7.
47. van den Heijkant M, Haider N, Taylor C, Subramaniam R. Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair. Pediatr Surg Int. 2011;27(7):781–5. In a group of children managed with regular irrigations of the augmented bladder, monitored by a clinical nurse specialist, the rate of stone formation was 7 % and there were no cases of recurrent UTI at 48 months of follow-up.
48. N’Dow J, Robson CN, Matthews JN, Neal DE, Pearson JP. Reducing mucus production after urinary reconstruction: a prospective randomized trial. J Urol. 2001;165(5):1433–40.
49. Nakhal RS, Wood D, Woodhouse C, Creighton SM. False-positive pregnancy tests following enterocystoplasty. BJOG. 2012;119(3):366–8.
50. DeFoor W, Tackett L, Minevich E, Wacksman J, Sheldon C. Risk factors for spontaneous bladder perforation after augmentation cystoplasty. Urology. 2003;62(4):737–41.
51. Metcalfe PD, Casale AJ, Kaefer MA, Misseri R, Dussinger AM, Meldrum KK, et al. Spontaneous bladder perforations: a report of 500 augmentations in children and analysis of risk. J Urol. 2006;175(4):1466,70. discussion 1470–1.
52. Shekarriz B, Upadhyay J, Demirbilek S, Barthold JS, Gonzalez R. Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology. 2000;55(1):123–8.
53. Woodhouse CR, North AC, Gearhart JP. Standing the test of time: long-term outcome of reconstruction of the exstrophy bladder. World J Urol. 2006;24(3):244–9.
54. Austin JC, Elliott S, Cooper CS. Patients with spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival. J Urol. 2007;178(3 Pt 1):798–801.
55. Husmann DA. Malignancy after gastrointestinal augmentation in childhood. Ther Adv Urol. 2009;1(1):5–11.
56. Soergel TM, Cain MP, Misseri R, Gardner TA, Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172(4 Pt 2):1649,51. discussion 1651–2.
57. Husmann DA, Rathbun SR. Long-term follow up of enteric bladder augmentations: the risk for malignancy. J Pediatr Urol. 2008;4(5):381,5. discussion 386.
58. Castellan M, Gosalbez R, Bar-Yosef Y, Labbie A. Complications after use of gastric segments for lower urinary tract reconstruction. J Urol. 2012;187(5):1823–7. In a review of 29 patients, the authors recommend against performing gastrocystoplasty, citing a 52 % complication rate. Three patients required re-augmentation with a different enteric segment and three patients developed metastatic adenocarcinoma. All of the patients who developed adenocarcinoma died from disease progression despite aggressive surgical management.
59. Vemulakonda VM, Lendvay TS, Shnorhavorian M, Joyner BD, Kaplan H, Mitchell ME, et al. Metastatic adenocarcinoma after augmentation gastrocystoplasty. J Urol. 2008;179(3):1094,6. discussion 1097.
60. Kao CS, Kum JB, Fan R, Grignon DJ, Eble JN, Idrees MT. Nephrogenic adenomas in pediatric patients: a morphologic and immunohistochemical study of 21 cases. Pediatr Dev Pathol. 2013;16(2):80–5.
61. Franke EI, Misseri R, Cain MP, Kaefer M, Meldrum KK, Fan R, et al. Nephrogenic adenoma in the augmented bladder. J Urol. 2011;186(4 Suppl):1586–9.
62. Barrington JW, Fulford S, Griffiths D, Stephenson TP. Tumors in bladder remnant after augmentation enterocystoplasty. J Urol. 1997;157(2):482,5. discussion 485–6.
63. Filmer RB, Spencer JR. Malignancies in bladder augmentations and intestinal conduits. J Urol. 1990;143(4):671–8.
64. Ramamurthy R, Susikar S. Approaches to management of adenocarcinoma following colocystoplasty. Gulf J Oncolog. 2013;1(13):87–91.
65. Higuchi TT, Fox JA, Husmann DA. Annual endoscopy and urine cytology for the surveillance of bladder tumors after enterocystoplasty for congenital bladder anomalies. J Urol. 2011;186(5):1791–5. Two hundred fifty endoscopies performed in 65 patients beginning 10 years after AE found 4 lesions, all of which were benign. Specificity of urine cytology was found to be 90 %. Due to the low incidence of malignancy and high cost of yearly surveillance cystoscopy, the authors recommend against performing yearly cystoscopy and urine cytology.
66. Kokorowski PJ, Routh JC, Borer JG, Estrada CR, Bauer SB, Nelson CP. Screening for malignancy after augmentation cystoplasty in children with spina bifida: a decision analysis. J Urol. 2011;186(4):1437–43. Based on a decision analysis model, yearly cystoscopy and urine cytology would be cost effective if the incidence of cancer was more than 2.5 times greater than the currently estimated lifetime risk in the AE population.